The British Journal of Cardiology

APRIL 2, 2025

This report provides findings from a cross-sectional survey of community HF services in the UK between September 2021 and February 2022. All services reviewed patients with HF with reduced ejection fraction (HFrEF), only 58% reviewed patients with HF with preserved ejection fraction (HFpEF).

Heart Failure 40

Heart Failure Preserved Ejection Fraction Nursing Pharmacology 40

The British Journal of Cardiology

JANUARY 14, 2025

Here we describe the findings from a cross-sectional survey of HF services in the UK performed between September 2021 and February 2022. Heart failure (HF) is a significant problem in the UK with variation in services across the country. Seventy-nine responses describing hospital-based HF services from all devolved countries were received.

Heart Failure 49

Heart Failure Preserved Ejection Fraction Hospital Inpatient 49

Open Heart

APRIL 24, 2024

Results Data were collected in April 2012 to January 2014 and in June 2021 to December 2022. HF with preserved ejection fraction (HFpEF) was the most common phenotype and increased significantly compared with the first period (46.3% and 29.2%, p<0.001).

Heart Failure 52

Heart Failure Preserved Ejection Fraction ACE Inhibitor Pharmacology 52

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies."

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies."

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Journal of the American Heart Association

MARCH 8, 2024

BackgroundContemporary use of sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) and angiotensin receptor‐neprilysin inhibitors (ARNi) in patients with atrial fibrillation (AF) and heart failure (HF) has not been described.Methods and ResultsWe analyzed the MarketScan databases for the period January 1, 2021 to July 30, 2022.

Atrial Fibrillation 65

Atrial Fibrillation Preserved Ejection Fraction Heart Failure 65

DAIC

FEBRUARY 22, 2024

A team of scientists from the medical schools at Wake Forest University, Duke University and Thomas Jefferson University are examining whether a novel physical rehabilitation intervention will reduce rehospitalizations and mortality in patients hospitalized for heart failure with preserved ejection fraction (HFpEF).

Heart Failure 105

Heart Failure Research Preserved Ejection Fraction Hospital 105